《美股業績》聯合健康(UNH.US)季績勝預期 市場關注醫保報銷率下調影響
道指成分股、美國醫保集團聯合健康(UNH.US)公布首季純利按年升12%至56.11億美元,每股季度攤薄純利5.95美元,經調整後為6.26美元,高於市場預期的6.13美元。季度收人按年升15%至919.31億美元。
聯合健康料今年度每股經調整盈利介乎24.5至25美元,與早前預測相若,市場預期為24.94美元。美國政府明年就醫療保險報銷率將平均減少1.1%,該指標影響醫保公司可收取每月保費、提供的保險計劃及盈利。市場關注措施影響公司推出的醫保代替計劃。
該股上周五(16日)跌2.7%報511.79美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.